Anixa Biosciences Stock Probability of Future Stock Price Finishing Over 3.08

ANIX Stock  USD 3.20  0.14  4.58%   
Anixa Biosciences' future price is the expected price of Anixa Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Anixa Biosciences performance during a given time horizon utilizing its historical volatility. Check out Anixa Biosciences Backtesting, Anixa Biosciences Valuation, Anixa Biosciences Correlation, Anixa Biosciences Hype Analysis, Anixa Biosciences Volatility, Anixa Biosciences History as well as Anixa Biosciences Performance.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.
  
At this time, Anixa Biosciences' Price To Sales Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.35 in 2024, whereas Price Earnings Ratio is likely to drop (9.43) in 2024. Please specify Anixa Biosciences' target price for which you would like Anixa Biosciences odds to be computed.

Anixa Biosciences Target Price Odds to finish over 3.08

The tendency of Anixa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 3.08  in 90 days
 3.20 90 days 3.08 
about 80.43
Based on a normal probability distribution, the odds of Anixa Biosciences to stay above $ 3.08  in 90 days from now is about 80.43 (This Anixa Biosciences probability density function shows the probability of Anixa Stock to fall within a particular range of prices over 90 days) . Probability of Anixa Biosciences price to stay between $ 3.08  and its current price of $3.2 at the end of the 90-day period is about 19.18 .
Given the investment horizon of 90 days Anixa Biosciences has a beta of 0.86. This suggests Anixa Biosciences market returns are sensitive to returns on the market. As the market goes up or down, Anixa Biosciences is expected to follow. Additionally Anixa Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Anixa Biosciences Price Density   
       Price  

Predictive Modules for Anixa Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Anixa Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.163.207.41
Details
Intrinsic
Valuation
LowRealHigh
1.095.309.51
Details
Naive
Forecast
LowNextHigh
0.062.947.15
Details
2 Analysts
Consensus
LowTargetHigh
10.9212.0013.32
Details

Anixa Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Anixa Biosciences is not an exception. The market had few large corrections towards the Anixa Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Anixa Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Anixa Biosciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.0049
β
Beta against Dow Jones0.86
σ
Overall volatility
0.21
Ir
Information ratio -0.0052

Anixa Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Anixa Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Anixa Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Anixa Biosciences generated a negative expected return over the last 90 days
Anixa Biosciences has high historical volatility and very poor performance
The company reported the previous year's revenue of 210 K. Net Loss for the year was (9.93 M) with profit before overhead, payroll, taxes, and interest of 127.5 K.
Anixa Biosciences currently holds about 31.66 M in cash with (6.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Anixa Biosciences has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Anixa stock rises as Bitcoin added to treasury - Seeking Alpha

Anixa Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Anixa Stock often depends not only on the future outlook of the current and potential Anixa Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anixa Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding31 M
Cash And Short Term Investments23.8 M

Anixa Biosciences Technical Analysis

Anixa Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Anixa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Anixa Biosciences. In general, you should focus on analyzing Anixa Stock price patterns and their correlations with different microeconomic environments and drivers.

Anixa Biosciences Predictive Forecast Models

Anixa Biosciences' time-series forecasting models is one of many Anixa Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Anixa Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Anixa Biosciences

Checking the ongoing alerts about Anixa Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Anixa Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Anixa Biosciences generated a negative expected return over the last 90 days
Anixa Biosciences has high historical volatility and very poor performance
The company reported the previous year's revenue of 210 K. Net Loss for the year was (9.93 M) with profit before overhead, payroll, taxes, and interest of 127.5 K.
Anixa Biosciences currently holds about 31.66 M in cash with (6.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Anixa Biosciences has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Anixa stock rises as Bitcoin added to treasury - Seeking Alpha

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.